Pulmonary burns in children

Insights

Effective management of pediatric inhalation injuries requires tailored treatment. Key stages include bronchospasm, pulmonary edema, and bronchopneumonia, necessitating specific interventions for optimal outcomes in children.

Area of Science:

  • Pediatric critical care medicine
  • Burn management
  • Respiratory physiology

Background:

  • Inhalation injuries pose significant risks to children following burns.
  • Understanding the distinct clinical progression is crucial for effective management.
  • A 15-year experience with 101 pediatric patients informs current treatment strategies.

Purpose of the Study:

  • To outline essential concepts for managing children with inhalation injuries.
  • To correlate treatment strategies with the pathophysiologic stages of injury.
  • To improve outcomes through evidence-based interventions.

Main Methods:

  • Clinical observation of 101 children with inhalation injuries over 15 years.
  • Identification of three distinct clinical stages: bronchospasm, pulmonary edema, and bronchopneumonia.
  • Analysis of treatment efficacy based on adherence to pathophysiologic states.

Main Results:

  • Children progress through predictable stages: bronchospasm (1-12 hr), pulmonary edema (6-72 hr), and bronchopneumonia (>60 hr).
  • Successful outcomes correlate with aseptic pulmonary toilet, judicious tracheotomy, and mechanical ventilation for hypoxemia/edema.
  • Corticosteroids are indicated for bronchospasm; antibiotics are reserved for confirmed pneumonia.

Conclusions:

  • Treatment must align with the specific pathophysiologic stage of inhalation injury in children.
  • Aseptic pulmonary care and appropriate ventilatory support are paramount.
  • Prophylactic antibiotics are not recommended; targeted therapy based on cultures is essential.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...